Interventional oncology represents a rapidly advancing subspecialty of interventional radiology, emphasizing the diagnosis and treatment of cancer through minimally invasive techniques. It utilizes advanced imaging modalities such as ultrasound, CT scans, and MRI to direct targeted therapies precisely to tumors. Techniques include transarterial chemoembolization (TACE), selective internal radiation treatment (SIRT), and thermal ablation (including radiofrequency and microwave ablation). These methods ensure precise treatment while safeguarding healthy tissues, leading to diminished recovery time and fewer complications when compared to conventional cancer treatments.

According to SPER market research, ‘Global Interventional Oncology Market Size- By Technique, By Procedure, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Interventional Oncology Market is predicted to reach 6.77 billion by 2034 with a CAGR of 8.81%.

Drivers:

The expansion of the interventional oncology market is influenced by several critical factors, including the increasing global prevalence of cancer, a heightened demand for minimally invasive treatment alternatives, and ongoing technological improvements. Advancements in the occurrence of cancers affecting the liver, lungs, kidneys, and colon are being observed, many of which exhibit poor resectability. This trend highlights the growing number of procedures in interventional oncology, such as transarterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE), or percutaneous ablation. Such methods facilitate targeted tumor destruction with reduced systemic toxicity, shorter recovery periods, and fewer complications compared to traditional surgical and chemotherapeutic approaches.

Download Free Sample Detailed Report - https://www.sperresearch.com/report-store/interventional-oncology-market?sample=1

Restraints:

The interventional oncology market faces challenges due to the shortage of adequately trained and skilled interventional radiologists and oncologists, potentially hindering the broader adoption of advanced minimally invasive cancer treatments. Interventional oncology methods such as tumour ablation, TACE, and TARE require highly specialised expertise in image-guided approaches, catheter navigation, and accurate tumour targeting. The complexity of these procedures demands substantial training, access to cutting-edge imaging equipment, and in-depth understanding of tumor biology for optimal treatment outcomes.

The North American interventional oncology market led the global sector in 2024, accounting for the majority of revenue due to a number of factors, including the presence of major market players in the region, significant healthcare spending, increased awareness of minimally invasive procedures, a favourable regulatory environment, and a high cancer prevalence. Medtronic plc, Boston Scientific Corporation, Johnson & Johnson (Ethicon), Cook Medical, AngioDynamics Inc, and others are among the market's leading participants.

For More Information, refer to below link: –

Interventional Oncology Market Size

Related Reports:

Seasonal Affective Disorder Therapeutics Market 

Knee Osteoarthritis Drugs Market

Follow Us –  

LinkedIn | Instagram | Facebook | Twitter  

Contact Us:  

Sara Lopes, Business Consultant — USA  

SPER Market Research  

enquiries@sperresearch.com  

+1–347–460–2899